Shanghai Shengdi Pharmaceutical Co., Ltd.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a pharmaceutical and health enterprise engaged in pharmaceutical innovation and the research, development, production, and promotion of high-quality drugs. Founded in 1970, it was listed on the Shanghai Stock Exchange in 2000. By the end of 2018, it had more than 20,000 employees globally. It is a well-known domestic supplier of anti-tumor drugs, surgical medications, and contrast agents, and serves as the leading unit of the national industry-university-research alliance for anti-tumor drug technology innovation. It has established a national engineering technology research center for targeted drugs and a post-doctoral research workstation.
Shanghai Shengdi Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Jiangsu Hengrui Pharmaceuticals Co., Ltd. The company is located in Zhangjiang Hi-Tech Park, Pudong, Shanghai, with a registered capital of 250 million yuan and a land area of 14,000 square meters. As an important part of Hengrui's new drug research and development, Shanghai Shengdi has core functions including clinical medicine, central medical affairs, central marketing, preclinical development, new drug coordination, business development, translational medicine, and external R&D collaboration.